What is she best known for?
The fields of study she is best known for:
Cancer research, Mutation, Cancer, Pancreatic cancer and Genetics are her primary areas of study.
Her work in Cancer research addresses subjects such as Immunology, which are connected to disciplines such as Stromal cell.
The various areas that Lynda Chin examines in her Cancer study include Exome sequencing, Genome, Comparative genomics and Mutation rate.
Her Pancreatic cancer research includes elements of Fibrosis, KRAS and Pancreas.
Lynda Chin focuses mostly in the field of Tumor microenvironment, narrowing it down to matters related to genomic DNA and, in some cases, Molecular biology.
Her Molecular biology research includes themes of Germline mutation, Oncogene, microRNA, Gene and Adenocarcinoma of the lung.
Her most cited work include:
- Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network (2762 citations)
- Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival. (1155 citations)
- Identification of Double Stranded Genomic DNA Spanning all Chromosomes with Mutated KRAS and p53 DNA in the Serum Exosomes of Patients with Pancreatic Cancer (532 citations)
What are the main themes of her work throughout her whole career to date?
Her scientific interests lie mostly in Cancer research, Genetics, Cancer, Melanoma and Gene.
The concepts of her Cancer research study are interwoven with issues in Pancreatic cancer, Immunology, Cell cycle, Histone and Epigenetics.
Her Cancer study combines topics from a wide range of disciplines, such as Cell culture, Precision medicine, Molecular biology and In vivo.
In general Gene study, her work on Structural variation, RNA interference, Breakpoint and Exon often relates to the realm of Transcriptome, thereby connecting several areas of interest.
Her study explores the link between Mutation and topics such as DNA that cross with problems in Somatic cell.
As part of one scientific family, Lynda Chin deals mainly with the area of Tumor microenvironment, narrowing it down to issues related to the Microvesicles, and often genomic DNA.
She most often published in these fields:
- Cancer research (58.33%)
- Genetics (37.50%)
- Cancer (29.17%)
What were the highlights of her more recent work (between 2016-2020)?
- Genetics (37.50%)
- Gene (21.87%)
- Histone (16.67%)
In recent papers she was focusing on the following fields of study:
Lynda Chin spends much of her time researching Genetics, Gene, Histone, PTEN and Melanoma.
As part of her studies on Gene, Lynda Chin frequently links adjacent subjects like RPTOR.
Her PTEN study combines topics in areas such as STK11 and Protein kinase B.
Her biological study spans a wide range of topics, including Cancer and Uveal Neoplasm.
In her papers, Lynda Chin integrates diverse fields, such as Epigenome and Cancer research.
Lynda Chin interconnects YAP1, Cell cycle and ChIA-PET in the investigation of issues within Cancer research.
Between 2016 and 2020, her most popular works were:
- Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma (302 citations)
- A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations (209 citations)
- A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations (209 citations)
In her most recent research, the most cited papers focused on:
Genetics, PTEN, PI3K/AKT/mTOR pathway, STK11 and Gene are her primary areas of study.
Her work in the fields of Genetics, such as BAP1, Mutation and Uveal Neoplasm, intersects with other areas such as GNA11 and Monosomy.
Her PTEN research integrates issues from Protein kinase B and RPTOR.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
